You are here: Industry Insights > CFDA

News List

Single-lead ECG Wristband developed by Lifesense Health Officially Passes CFDA Certification prnasia
August 06, 2019
On July 22 2019, a watch-type single-lead electrocardiogram ("ECG") wristband developed by Guangdong Lifesense Health Electronics Co., Ltd. ("Lifesense Health") (stock code: 300562) officially received China Food and ...
FLAMMA announces the successful CFDA inspection of Flamma Honkai cphi-online
April 11, 2019
FLAMMA announces the successful CFDA inspection of Flamma Honkai
Esco Medical secures CFDA approval for Embryo Incubators biospectrum
November 14, 2018
The fundamental design concept behind MIRI and MIRI TL improves upon the Silent Embryo Hypothesis by minimizing stressful factors that may be introduced when taking the dishes out of the incubator.
Ascletis' NDA for its all-oral HCV treatment accepted by CFDA biospectrumasia
August 02, 2018
Ravidasvir in combination with Ganovo (RDV/DNV Regimen) is the first all-oral interferon-free HCV regimen developed by a domestic company in China
Latest Release of CFDA! The Upgraded and Implemented Data Protection System to Help Chinese Innovative Drugs Xiaoyaowan
May 15, 2018
The Office of CFDA has started to seek public opinions on Implementation Measures for Drug Trial Data Protection (Interim) on April 26
A Glimpse of the Latest Developments of the Second Half of Consistency Evaluation through the Top 5 Varieties Xiaoyaowan
April 17, 2018
CFDA has generated 110 acceptance numbers for the generic drug consistency evaluation applications accepted by April 2, 2018, involving 51 varieties of 53 pharmaceutical enterprises.
Regulation of Pharmaceutical Production will be Stricter with the Cancellation of GMP Certification CPhI-China
March 07, 2018
The Amendment of the Drug Administration Law of the People's Republic of China (Draft for Comment) proposes to cancel the GMP certification and GSP certification, and change the APIs and excipients to be approved together with pharmaceutical products.
CFDA approves Luxury Skincare Products of CBD Biotechnology biospectrumasia
February 07, 2018
CBD Biotechnology Co. Ltd.'s New Luxury Skincare Products Have Been Approved by the CFDA and Will Launch in China in February 2018
Opdivo May Be the First Marketed in China, Chinese Pharmaceutical Enterprises are Catching up Fast! Zhixing
January 17, 2018
Anti-PD-1 monoclonal antibodies are very popular with pharmaceutical enterprises, however, it is hard to find such monoclonal antibody in China.
Current Situation of Biosimilars in China III: Analysis of Biosimilars of Five Blockbusts Tang
January 16, 2018
The biosimilars in China just started, and the biosimilar review and approval policies continue to be improved.

Previous page 1 2 3 Next page